STAT3 and neoplasm: Radioactivity peaked later in the tumor than in blood and muscle, which are representative nontarget tissues, suggesting active targeting of [18F]FBNAF to the tumor depending on the binding interaction with STAT3 in the xenograft mouse model used in this study.